文献速递泌尿生殖腹部CT

基于多期CT影像组学联合机器学习鉴别睾丸精原细胞瘤与非精原细胞瘤:一项多中心研究

Differentiation of testicular seminomas from nonseminomas based on multiphase CT radiomics combined with machine learning: A multicenter study.
PubMed 文献 · Eur J Radiol · 2024-03-07

该多中心研究纳入四家医院221例经病理证实的睾丸生殖细胞肿瘤患者,分为训练组126例、内部验证组55例和外部测试组40例,从CT图像提取影像组学特征并构建临床模型、影像组学模型及临床-影像组学模型。临床-影像组学模型判别能力最高,训练组、验证组和测试组AUC分别为0.918(95%CI 0.870-0.966)、0.909(95%CI 0.829-0.988)和0.839(95%CI 0.709-0.968),决策曲线分析证实联合模型净获益更大。

要点

  • 临床-影像组学联合模型鉴别精原细胞瘤与非精原细胞瘤的AUC在训练组、验证组和测试组分别为0.918、0.909和0.839。
  • 联合模型判别能力优于单独临床模型和单独影像组学模型。
  • 决策曲线分析显示联合模型预测精原细胞瘤与非精原细胞瘤的净获益更大。

核心结论

  • 临床-影像组学模型可作为无创鉴别睾丸精原细胞瘤与非精原细胞瘤的潜在工具,为临床治疗提供有价值指导。

研究设计与样本

  • 多中心研究,纳入四家医院经病理证实的睾丸生殖细胞肿瘤患者221例,分为训练组126例、内部验证组55例和外部测试组40例,从CT图像提取影像组学特征,经特征选择后用不同机器学习算法构建临床模型、影像组学模型和临床-影像组学模型,以受试者工作特征曲线分析选择最优模型并行决策曲线分析。

诊断标准与关键数值

  • 临床-影像组学模型在训练组AUC为0.918(95%CI 0.870-0.966)、内部验证组AUC为0.909(95%CI 0.829-0.988)、外部测试组AUC为0.839(95%CI 0.709-0.968)。

临床应用与阅片要点

  • 原文结论认为临床-影像组学模型可作为无创鉴别睾丸精原细胞瘤与非精原细胞瘤的潜在工具,为临床治疗提供有价值指导。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Differentiating seminomas from nonseminomas is crucial for formulating optimal treatment strategies for testicular germ cell tumors (TGCTs). Therefore, our study aimed to develop and validate a clinical-radiomics model for this purpose.

METHODS: In this study, 221 patients with TGCTs confirmed by pathology from four hospitals were enrolled and classified into training (n = 126), internal validation (n = 55) and external test (n = 40) cohorts. Radiomics features were extracted from the CT images. After feature selection, we constructed a clinical model, radiomics models and clinical-radiomics model with different machine learning algorithms. The top-performing model was chosen utilizing receiver operating characteristic (ROC) curve analysis. Decision curve analysis (DCA) was also conducted to assess its practical utility.

RESULTS: Compared with those of the clinical and radiomics models, the clinical-radiomics model demonstrated the highest discriminatory ability, with AUCs of 0.918 (95 % CI: 0.870 - 0.966), 0.909 (95 % CI: 0.829 - 0.988) and 0.839 (95 % CI: 0.709 - 0.968) in the training, validation and test cohorts, respectively. Moreover, DCA confirmed that the combined model had a greater net benefit in predicting seminomas and nonseminomas.

CONCLUSION: The clinical-radiomics model serves as a potential tool for noninvasive differentiation between testicular seminomas and nonseminomas, offering valuable guidance for clinical treatment.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Fang F, Wu L, Luo X, et al. Differentiation of testicular seminomas from nonseminomas based on multiphase CT radiomics combined with machine learning: A multicenter study. Eur J Radiol. 2024. PMID: 38460443. doi:10.1016/j.ejrad.2024.111416

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。